M1 macrophages were generated by stimulation with 100 ng/mL LPS (Escherichia coli, Sigma-Aldrich, United States) and 10 ng/mL IFN-γ (Sino Biological, Shanghai, China) for 24 h. RAW264.7 cells were induced with 10 ng/mL IL-4 and 10 ng/mL IL-13 (both purchased from Sino Biological) for 24 h to generate of M2 macrophages. LBP and LPS/IFN-γ treated simultaneously RAW264.7 cells for 24 h, or LBP alone treated RAW264.7 cells for 24 h. Fludarabine and AS1517499 (both purchased from TargetMol, Shanghai, China) were employed to validate the STAT1and STAT6 signaling pathways.
Lipopolysaccharides (lps)
LPS is a lab equipment product that serves as a lipopolysaccharide (LPS) standard. LPS is a key component of the outer membrane of Gram-negative bacteria and is commonly used in research and development applications.
Lab products found in correlation
6 protocols using lipopolysaccharides (lps)
RAW264.7 Macrophage Polarization Protocol
M1 macrophages were generated by stimulation with 100 ng/mL LPS (Escherichia coli, Sigma-Aldrich, United States) and 10 ng/mL IFN-γ (Sino Biological, Shanghai, China) for 24 h. RAW264.7 cells were induced with 10 ng/mL IL-4 and 10 ng/mL IL-13 (both purchased from Sino Biological) for 24 h to generate of M2 macrophages. LBP and LPS/IFN-γ treated simultaneously RAW264.7 cells for 24 h, or LBP alone treated RAW264.7 cells for 24 h. Fludarabine and AS1517499 (both purchased from TargetMol, Shanghai, China) were employed to validate the STAT1and STAT6 signaling pathways.
Modulation of LPS-Induced Microglial Inflammation
Cells were seeded in 96 well plates at 1 × 105 cells per well, then cultured for 24 h. These cells’ group distribution and administration were divided into the following groups (n = 3 per group): control group; LPS (5 μg/mL) group; LPS + TAK-242 (1 μM) group (TAK-242, a TLR4 inhibitor which can prevent LPS-induce inflammatory response, was used as positive control [32 (link),33 (link)]); and LPS + dutasteride (10 nM–20 μM) group. Cells were incubated with TAK-242 (TargetMol, Washington, USA, Catalog No. TQ0181) and dutasteride (TargetMol, Washington, DC, USA, Catalog No. T1499) for 1 h, and subsequently stimulated with LPS (TargetMol, Washington, DC, USA, Catalog No. T11855) for 24 h, then stored for later tests.
Macrophage Activation and Characterization
The cell pellets were resuspended in 100 μL of PBS containing 1.25 μg of PE-conjugated anti-mouse CD86 antibody and 0.25 μg of FITC-conjugated anti-mouse CD206 antibody (Biolegend). This step was performed on ice for 30 min to preserve cell viability and prevent nonspecific antibody binding. The expression of CD86 and CD206 was subsequently analyzed using the CytoFLEX flow cytometry system (Beckman Coulter). Additionally, the intracellular ROS level was detected using 2,7dichlorodihydrofluorescein diacetate (DCFH-DA; Yeasen), following the same procedure as described above (n = 3).
NRF2 Induction in Septic Kidney Cells
Icariin Modulates Airway Inflammation in OVA-Induced Asthma
Icariin (purity 98%), corticosterone, and LPS were purchased from TargetMol. OVA (grade V) and methacholine were provided by Sigma-Aldrich. Injectable Dex sodium phosphate was obtained from
Tianjin Pharmaceutical Group Xinzheng Company. Imject alum adjuvant, a formulation of aluminum hydroxide and magnesium hydroxide, was provided by Thermo Fisher Scientific Company. ELISA kits
for IL-4, IL-5, IL-6, IL-13, TNF-
α, interferon (INF)-
γ, and OVA-specific IgE were purchased from eBioscience Company. The CCK-8 assay was obtained from Dojindo Laboratories.
TransAM GR kits were purchased from Active Motif. Antibodies for phosphorylated p38 MAPK (Thr180/Tyr182, Cat. no. 4511), p38 MAPK (Cat. no.8690), and phosphorylated GR (S226, Cat. no.97 285)
were obtained from Cell Signaling Technology, and GR alpha (ab3580) was purchased from Abcam.
Neutrophil NETosis Induction by Amyloid-beta
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!